Written by Rachel Farrar, MSN, FNP-BC, PMHNP-B

Ongoing development of more effective weight loss medications, expanded insurance coverage for obesity treatments, and federal shifts in dietary guidance are reshaping how Americans approach weight management. Together, these changes suggest that 2026 may mark a year of increased success for individuals seeking sustainable weight loss.

Two widely used glucagon-like peptide-1 (GLP-1) receptor agonists—semaglutide and tirzepatide—are becoming more accessible as availability increases and costs decline. Insurance providers are increasingly recognizing their value in managing weight-related chronic conditions, including diabetes, fatty liver disease, and cardiovascular disease.

These medications act on both the brain and digestive system by: signaling fullness, slowing gastric emptying, and improving insulin sensitivity.

An oral formulation of semaglutide is now available, and a third injectable medication, retatrutide, is currently in the FDA approval process.

Some critics describe GLP-1 medications as “cheating,” arguing that they remove willpower from the weight loss equation. This perspective overlooks their role as tools that help bridge the gap between knowing how to lose weight and being able to consistently follow a plan.

Medication alone is not sufficient. Effective use requires a structured approach that includes: regular physical activity, particularly resistance or strength training, and a nourishing diet rich in protein and fiber.

Without changes in how food is chosen and balanced—not simply how much is eaten—individuals risk nutritional deficiencies as well as loss of muscle mass and bone density alongside weight reduction.
Older and Alternative

Weight Loss Medications

Despite newer options, many weight loss practices continue to prescribe older stimulant medications such as phentermine and diethylpropion. These drugs suppress appetite and increase metabolic rate, often producing early weight loss followed by a plateau as effectiveness diminishes over time. For some patients, they may also cause cardiovascular side effects, including elevated blood pressure and heart rate.

Non-stimulant alternatives include topiramate, which may be prescribed alone or in combination with phentermine in a medication marketed as Qsymia. Another option, Plenity, is a non-drug product composed of cellulose particles that absorb water and expand in the stomach, promoting a sense of fullness before passing through the gastrointestinal tract without being absorbed.

Lipotropic Injections

Lipotropic injections are sometimes promoted as a more natural approach to weight loss, though research findings on their effectiveness are mixed. These injections typically contain vitamin B6, methionine, inositol, and choline—compounds that may support fat metabolism—and are usually administered intramuscularly once or twice per week.

Regardless of their impact on weight, several of these ingredients offer independent health benefits. Inositol has been associated with improvements in depression/anxiety, while choline supports brain, liver, and cardiovascular function.

The Importance of Whole-Person Care

Weight changes may also occur with appropriate hormone replacement therapy, improved thyroid management, or treatment of sleep-related disorders. In some cases, a relatively simple intervention—such as discontinuing a medication known to promote weight gain—can lead to meaningful results.
For this reason, healthcare providers should evaluate the full clinical picture when discussing weight loss options and ensure that patients have the opportunity to ask questions and make informed decisions. All prescription therapies carry potential side effects and should be considered through an honest risk–benefit analysis.

Ultimately, the most effective long-term weight management strategies remain accessible to everyone. A whole-food, minimally processed diet and consistent daily movement require no prescription, no insurance approval, and carry minimal risk. While medical therapies can be valuable tools, sustainable success continues to rest on foundational lifestyle choices.

Rachel Farrar, MSN, FNP-BC, PMHNP-BC, is the founder and Nurse Practitioner at Lake Anna Integrative Care, dual-certified Nurse Practitioner in Family Practice and Psychiatric-Mental Health. Rachel brings two decades of experience in primary care, urgent care, and occupational medicine. She earned her Master of Science in Nursing from the University of Virginia in 2003, then completed a post-graduate Mental Health program at Radford University and advanced training in Functional Medicine.

Jen Bailey

Hi! I’m Jennifer Bailey and I partner with entrepreneurs who have massive ideas that could change the world. Most marketing is meaningless. Filled with empty promises, its only job is to bring in new traffic, new leads, and new customers. But I’ve drawn a line in the sand, and I’ve learned that marketing can do so much more than reach business goals and build profit. My methods give businesses the fire and soul they need to reach the right people, set the groundwork for sustainable relationships, and offer true value to the people on both the giving and receiving ends of marketing.

Read more about me here